AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionCheviot Value Management, LLC
Latest Disclosed Ownership28,080 shares
Latest Disclosed Value $ 6,107,172
Cheviot Value Management, LLC reports 0.13% decrease in ownership of 4AB / AbbVie Inc.

On May 12, 2026 - Cheviot Value Management, LLC filed a 13F-HR form disclosing ownership of 28,080 shares of AbbVie Inc. (DE:4AB) valued at $5,206,032 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 28,117 shares of AbbVie Inc.. This represents a change in shares of -0.13% during the quarter. The current value of the position is $5,293,080 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ABBVIE INC COM Stock 00287Y109 28,080 -37 -0.13 6,107 -0.67 0.6134
2026-02-03 2025-12-31 13F ABBVIE INC COM Stock 00287Y109 28,117 -427 -1.50 6,148 -5.33 0.6039
2025-10-31 2025-09-30 13F ABBVIE INC COM Stock 00287Y109 28,544 -293 -1.02 6,495 13.71 0.6908
2025-08-13 2025-06-30 13F ABBVIE INC COM Stock 00287Y109 28,837 -260 -0.89 5,711 0.12 0.6548
2025-05-09 2025-03-31 13F ABBVIE INC COM Stock 00287Y109 29,097 -960 -3.19 5,705 6.80 0.7017
2025-02-14 2024-12-31 13F Abbvie COM 00287Y109 30,057 -37 -0.12 5,341 -10.13 1.0212
2024-11-14 2024-09-30 13F Abbvie COM 00287Y109 30,094 -1,173 -3.75 5,943 10.84 1.1211
2024-08-14 2024-06-30 13F Abbvie COM 00287Y109 31,267 -607 -1.90 5,363 -7.62 1.0475
2024-05-14 2024-03-31 13F Abbvie COM 00287Y109 31,874 -503 -1.55 5,804 13.43 1.2723
2024-02-14 2023-12-31 13F Abbvie COM 00287Y109 32,377 -2,031 -5.90 5,117 -0.21 1.1018
2023-11-07 2023-09-30 13F Abbvie COM 00287Y109 34,408 -245 -0.71 5,129 9.85 1.1353
2023-11-07 2023-06-30 13F Abbvie COM 00287Y109 34,653 762 2.25 4,669 -13.57 1.0169
2023-05-15 2023-03-31 13F Abbvie COM 00287Y109 33,891 -388 -1.13 5,401 -4.37 1.2989
2023-02-13 2022-12-31 13F Abbvie COM 00287Y109 34,279 -19 -0.06 5,649 22.70 1.3898
2022-11-14 2022-09-30 13F Abbvie COM 00287Y109 34,298 -367 -1.06 4,603 -13.30 1.2578
2022-08-03 2022-06-30 13F Abbvie COM 00287Y109 34,665 -135 -0.39 5,309 -5.89 1.3245
2022-05-11 2022-03-31 13F Abbvie COM 00287Y109 34,800 2,099 6.42 5,641 27.39 1.1940
2022-02-14 2021-12-31 13F Abbvie COM 00287Y109 32,701 -182 -0.55 4,428 24.84 1.0376
2021-11-12 2021-09-30 13F Abbvie COM 00287Y109 32,883 -27 -0.08 3,547 -4.32 0.9096
2021-08-16 2021-06-30 13F Abbvie COM 00287Y109 32,910 -308 -0.93 3,707 3.12 0.9101
2021-05-14 2021-03-31 13F Abbvie COM 00287Y109 33,218 2,217 7.15 3,595 8.22 0.9991
2021-02-12 2020-12-31 13F Abbvie COM 00287Y109 31,001 971 3.23 3,322 26.31 1.0026
2020-11-12 2020-09-30 13F Abbvie COM 00287Y109 30,030 -90 -0.30 2,630 -11.06 0.9123
2020-08-17 2020-06-30 13F Abbvie COM 00287Y109 30,120 -865 -2.79 2,957 25.24 1.1535
2020-05-13 2020-03-31 13F Abbvie COM 00287Y109 30,985 -778 -2.45 2,361 -16.04 1.0764
2020-02-12 2019-12-31 13F Abbvie COM 00287Y109 31,763 -708 -2.18 2,812 14.36 1.0835
2019-11-15 2019-09-30 13F Abbvie COM 00287Y109 32,471 -185 -0.57 2,459 3.54 1.0475
2019-08-14 2019-06-30 13F Abbvie COM 00287Y109 32,656 -103 -0.31 2,375 -10.04 1.0279
2019-05-14 2019-03-31 13F Abbvie COM 00287Y109 32,759 -716 -2.14 2,640 -14.45 1.2825
2019-02-14 2018-12-31 13F Abbvie COM 00287Y109 33,475 -10,070 -23.13 3,086 -25.06 1.6067
2018-11-13 2018-09-30 13F Abbvie COM 00287Y109 43,545 -1,699 -3.76 4,118 -1.77 1.9343
2018-08-10 2018-06-30 13F Abbvie COM 00287Y109 45,244 -1,696 -3.61 4,192 -5.65 2.0545
2018-05-11 2018-03-31 13F Abbvie COM 00287Y109 46,940 -8,878 -15.91 4,443 -17.69 2.3107
2018-02-13 2017-12-31 13F Abbvie COM 00287Y109 55,818 -5,054 -8.30 5,398 -0.20 2.7962
2017-11-14 2017-09-30 13F Abbvie COM 00287Y109 60,872 -1,095 -1.77 5,409 20.39 2.9403
2017-08-11 2017-06-30 13F Abbvie COM 00287Y109 61,967 -8,584 -12.17 4,493 -2.26 2.6179
2017-05-11 2017-03-31 13F Abbvie COM 00287Y109 70,551 -682 -0.96 4,597 3.05 2.5895
2017-02-14 2016-12-31 13F Abbvie COM 00287Y109 71,233 86 0.12 4,461 -0.58 2.6710
2016-11-14 2016-09-30 13F Abbvie COM 00287Y109 71,147 -1,921 -2.63 4,487 -0.82 2.7854
2016-08-12 2016-06-30 13F Abbvie COM 00287Y109 73,068 -699 -0.95 4,524 7.36 2.7034
2016-05-13 2016-03-31 13F AbbVie COM 00287Y109 73,767 -584 -0.79 4,214 -4.34 2.6934
2016-02-11 2015-12-31 13F AbbVie COM 00287Y109 74,351 -570 -0.76 4,405 8.07 2.8538
2015-11-13 2015-09-30 13F AbbVie COM 00287Y109 74,921 -1,664 -2.17 4,076 -20.79 2.7090
2015-08-14 2015-06-30 13F AbbVie COM 00287Y109 76,585 -311 -0.40 5,146 14.33 3.0406
2015-05-13 2015-03-31 13F AbbVie COM 00287Y109 76,896 1,073 1.42 4,501 -9.29 2.6537
2015-02-13 2014-12-31 13F AbbVie COM 00287Y109 75,823 -2,453 -3.13 4,962 9.75 2.8896
2014-11-12 2014-09-30 13F AbbVie COM 00287Y109 78,276 -3,618 -4.42 4,521 -2.19 2.6233
2014-08-13 2014-06-30 13F AbbVie COM 00287Y109 81,894 -12,393 -13.14 4,622 -4.62 2.4681
2014-05-14 2014-03-31 13F AbbVie COM 00287Y109 94,287 -6,346 -6.31 4,846 -8.81 2.6728
2014-02-12 2013-12-31 13F AbbVie COM 00287Y109 100,633 -3,120 -3.01 5,314 14.50 2.9333
2013-11-13 2013-09-30 13F AbbVie COM 00287Y109 103,753 -4,547 -4.20 4,641 3.66 2.5603
2013-08-13 2013-06-30 13F AbbVie COM 00287Y109 108,300 -132,440 -55.01 4,477 -54.40 2.4439
2013-05-21 2013-03-31 13F AbbVie COM 00287Y109 240,740 240,740 9,817 2.2944
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.